Clinical Trials Browser

Phase 1/2 × trioctyl phosphine oxide × Thoracic × Clear all

NCT00521144 2015-05-05

Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors

Phase 1/2 Completed

22 enrolled 9 charts

Small Cell Lung Carcinoma